2269.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 04:08):

Stats
Today's Volume	49.29M
Average Volume	68.67M
Market Cap	53.75B
EPS	HKD0 ( 2024-03-26 )
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	15.20
ATR14	HKD0.0240 (0.19%)

Volume Correlation

Long: -0.09 (neutral)

Short: 0.77 (moderate)

Signal:(33.25) Neutral

WuXi Biologics (Cayman) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

WuXi Biologics (Cayman) Correlation - Currency/Commodity

-0.33
( neutral )

-0.08
( neutral )

0.00
( neutral )

0.21
( neutral )

0.16
( neutral )

WuXi Biologics (Cayman) Financials

Annual	2022
Revenue:	HKD15.27B
Gross Profit:	HKD6.72B (44.04 %)
EPS:	HKD1.060

Q2	2023
Revenue:	HKD4.25B
Gross Profit:	HKD1.78B (41.93 %)
EPS:	HKD0.260

Q1	2023
Revenue:	HKD4.25B
Gross Profit:	HKD1.78B (41.93 %)
EPS:	HKD0.260

Q4	2022
Revenue:	HKD4.03B
Gross Profit:	HKD1.66B (41.07 %)
EPS:	HKD0.210

Financial Reports:

No articles found.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.